top of page
Rinnit logo – modern health products and health news

VA-ECMO (Veno-Arterial Extracorporeal Membrane Oxygenation)

Oct 11
6 min read

Updated: 3 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

VA-ECMO (veno-arterial extracorporeal membrane oxygenation) is a temporary form of life support that takes over the work of both the heart and the lungs. [1] It is used in critical situations, such as cardiogenic shock or cardiac arrest, to circulate oxygen-rich blood through the body when the native organs cannot. [1] The procedure involves a specialized machine that adds oxygen to the blood and removes carbon dioxide, acting as a bridge until the underlying condition can be treated. [1]

Quick Answer

VA-ECMO is a life support system for severe heart or lung failure that draws blood from the veins, oxygenates it through an external membrane and returns it to the arteries so vital organs keep receiving oxygen. [1] It is typically used for five to seven days, letting the heart and lungs rest and recover during emergencies such as heart attacks. [1]

What the research says

  • Routine VA-ECMO has not been shown to lower 6-month mortality after heart-attack shock. An individual patient data meta-analysis of 9 randomised trials (1,114 patients; 4 trials with 611 patients tested VA-ECMO) found no significant 6-month mortality benefit for early routine loading devices such as VA-ECMO (HR 0.93; 95% CI 0.75-1.17), while mechanical support overall increased major bleeding (OR 2.64) and vascular complications (OR 4.43); patients with ST-elevation cardiogenic shock without risk of hypoxic brain injury did show lower mortality (HR 0.77) (Thiele et al., The Lancet, 2024) [2].

  • Hospital mortality remains high and complications are common. A meta-analysis of 32 studies (12,756 patients treated between 1994 and 2019) found a pooled in-hospital mortality of 62%, with renal failure in 51% and bleeding in 49% of patients, which is consistent with roughly 4 in 10 patients surviving to hospital discharge (Rajsic et al., Annals of Intensive Care, 2022) [3].

  • ECPR may improve brain-preserving survival in refractory cardiac arrest. A meta-analysis of 4 randomized trials found survival with favorable neurological outcome of 27% (59/220) with extracorporeal CPR versus 18% (39/213) with conventional CPR (OR 1.72; 95% CI 1.09-2.70), with the benefit clearest when the initial rhythm was shockable (Scquizzato et al., Artificial Organs, 2023) [4].

What Is VA-ECMO?

Veno-arterial extracorporeal membrane oxygenation, commonly referred to as VA-ECMO, is a sophisticated medical intervention that provides both cardiac and respiratory support. Unlike other forms of life support that may only assist the lungs, VA-ECMO functions as an artificial heart and lung system located outside the body. This technology is critical for maintaining blood flow and oxygenation when a patient's own organs are suddenly unable to meet the body's metabolic demands.

The term "veno-arterial" describes the specific path the blood takes through the machine's circuit. It is drained from the venous system, processed through an artificial membrane for oxygenation, and then pumped back into the arterial system to be distributed to vital tissues. [1] This process allows the native heart and lungs to rest [1], which is essential for recovery in cases of acute organ failure.

Common Indications for VA-ECMO

Healthcare teams utilize VA-ECMO as a temporary "bridge" to recovery, transplant, or further long-term mechanical support. [1]

Condition

Description

Cardiogenic Shock

A sudden inability of the heart to pump enough blood, often caused by heart attacks or cardiomyopathy. [1]

Cardiac Arrest

Used when standard CPR fails to restart the heart quickly, a process known as E-CPR. [1]

Primary Graft Dysfunction

Occurs when a donor heart fails to function adequately immediately following transplant surgery. [1]

Pulmonary Embolism

A severe blockage in the lungs that significantly impairs both heart and lung function.

VA-ECMO circuit diagram showing blood flow from the venous system to the oxygenator and back to the arteries. – rinnit.com

The VA-ECMO Procedure

The initiation and management of VA-ECMO require a highly trained multidisciplinary team, including surgeons, perfusionists, and critical care nurses.

Cannulation and Initiation

The procedure begins with sedation and anesthesia to ensure the patient is comfortable. [1] Surgeons place two large tubes, called cannulas, into major blood vessels, typically in the chest or groin. [1] The venous cannula drains oxygen-poor blood into the machine, while the arterial cannula returns oxygen-rich blood to the body. [1] Anticoagulation medications, such as heparin, are administered to prevent blood clots from forming within the artificial circuit. [1]

Continuous Monitoring

Once the patient is connected, the ECMO machine remains at the bedside, acting as an extension of the circulatory system. The care team monitors vital signs, blood oxygen levels, and heart function around the clock. [1] If the patient's condition stabilizes, sedation may be reduced to allow the team to assess brain function and overall responsiveness. [1]

Medical team monitoring a patient on VA-ECMO life support in an intensive care setting. – rinnit.com

Risks and Potential Complications

While VA-ECMO is a life-saving intervention, it is reserved for the most severe cases due to the potential for significant complications.

  • Bleeding and Clots: The use of anticoagulants increases the risk of internal bleeding, while the artificial surfaces of the machine can trigger blood clot formation. [1]

  • Organ Damage: Prolonged use may lead to kidney damage or fluid buildup in the lungs, known as pulmonary edema. [1]

  • Neurological Risks: In some cases, brain damage or stroke can occur due to changes in blood flow or clot migration.

  • Infection: As with any invasive procedure involving external tubes, there is an inherent risk of infection at the cannulation sites. [1]

Illustration of a patient transitioning from VA-ECMO support to recovery or further treatment. – rinnit.com

Recovery and Long-Term Outlook

The goal of VA-ECMO is to support the patient until their heart and lungs are strong enough to function independently. This period typically lasts between five and seven days. [1]

The Weaning Process

Weaning involves gradually reducing the amount of blood flow provided by the ECMO machine. [1] This forces the patient's native heart and lungs to slowly take back their normal workload. If the heart and lungs demonstrate sufficient strength, the cannulas are removed. If weaning is unsuccessful, the care team may discuss long-term options, such as a left ventricular assist device (LVAD) or a heart transplant. [1]

Conclusion

VA-ECMO is a powerful tool in modern emergency medicine, offering a chance at survival for patients in profound cardiac or respiratory distress. While the risks are substantial, the ability to provide temporary heart and lung function can be the difference between life and death. Success depends on the underlying condition, the speed of intervention, and the expertise of the dedicated ECMO care team.

Take the Next Step

If a loved one is facing a cardiac or respiratory emergency, consult with the critical care team to understand if VA-ECMO is a viable option and what the specific goals of support will be in their case.

Frequently Asked Questions

What does VA-ECMO stand for?

VA-ECMO stands for veno-arterial extracorporeal membrane oxygenation, a form of life support that assists both the heart and lungs.

Is VA-ECMO a permanent treatment?

No, it is a temporary bridge to recovery or further treatment, typically used for five to seven days.

How does the machine help the heart and lungs?

The machine takes over the work of the heart and lungs, allowing these organs to rest and recover from severe injury or shock.

What are the main risks of VA-ECMO?

The primary risks include bleeding, blood clots, infection, kidney damage, and potential brain injury.

What is E-CPR?

E-CPR is the use of VA-ECMO during cardiac arrest when standard CPR is unable to restart the heart quickly enough.

Why is heparin used during the procedure?

Heparin is an anticoagulant used to prevent blood from clotting as it flows through the artificial parts of the ECMO machine.

Who manages the VA-ECMO machine?

A specialized team of physicians, surgeons, nurses, and respiratory therapists manages the treatment around the clock.

How is blood returned to the patient's body?

Oxygen-rich blood is returned to the body through an arterial cannula placed in a major artery, such as the femoral artery.

What happens if a patient cannot be weaned off the machine?

If weaning fails, the care team may consider a heart transplant, a long-term assist device (LVAD), or palliative care.

What is the survival rate for patients on VA-ECMO?

Survival depends on the underlying condition, but research indicates about 4 in 10 patients survive cardiogenic shock cases.

Related Reading

ECMO (Extracorporeal Membrane Oxygenation): How It Works, Types, Risks, and Recovery explains how ECMO works, its types, risks and recovery.

VV-ECMO: Advanced Life Support for Respiratory Failure describes the ECMO type used when the lungs fail.

Intra-Aortic Balloon Pump (IABP) covers another short-term device that helps a weak heart pump.

References

  1. Cleveland Clinic. VA-ECMO. Cleveland Clinic. Last updated April 30, 2026. https://my.clevelandclinic.org/health/treatments/va-ecmo

  2. Thiele H, Møller JE, Henriques JPS, et al. Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up. The Lancet. 2024;404(10457):1019-1028. PMID 39236726. https://doi.org/10.1016/S0140-6736(24)01448-X

  3. Rajsic S, Treml B, Jadzic D, et al. Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications. Annals of Intensive Care. 2022;12(1):93. PMID 36195759. https://doi.org/10.1186/s13613-022-01067-9

  4. Scquizzato T, Bonaccorso A, Swol J, et al. Refractory out-of-hospital cardiac arrest and extracorporeal cardiopulmonary resuscitation: A meta-analysis of randomized trials. Artificial Organs. 2023;47(5):806-816. PMID 36929354. https://doi.org/10.1111/aor.14516

Medical disclaimer

The information provided in this article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Comments


bottom of page